Dietary Intervention Prevents Dyslipidemia Associated With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Individuals

被引:46
作者
Lazzaretti, Rosmeri K. [1 ]
Kuhmmer, Regina [1 ]
Sprinz, Eduardo [2 ,3 ]
Polanczyk, Carisi A. [1 ,3 ]
Ribeiro, Jorge P. [1 ,3 ]
机构
[1] Hosp Clinicas Porto Alegre, Div Cardiol, BR-90035007 Porto Alegre, RS, Brazil
[2] Hosp Clinicas Porto Alegre, Div Internal Med, Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Fac Med, Dept Med, Porto Alegre, RS, Brazil
关键词
AIDS; cholesterol; nutrition; HIV-INFECTED PATIENTS; PROTEASE INHIBITOR; CHOLESTEROL; AIDS; MANAGEMENT; TRIALS; ADULTS; LIPIDS; RECOMMENDATIONS; LIPODYSTROPHY;
D O I
10.1016/j.jacc.2011.11.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to evaluate the efficacy of dietary intervention on blood lipids of human immunodeficiency virus (HIV)-1-infected patients who are started on highly active antiretroviral therapy (HAART). Background Current guidelines recommend diet as first-step intervention for HIV-1-infected individuals with HAART-related dyslipidemia, but there is no evidence from randomized trials to support this recommendation. Methods Eighty-three HIV-1-infected patients, naive from HAART, were randomly assigned to HAART with dietary intervention (diet group, n = 43) or HAART without dietary intervention (control group, n = 40) for 12 months. Diet, according to the National Cholesterol Education Program, was given every 3 months. Before and after intervention, 24-h food records and lipid profile were obtained. Data were analyzed by intention to treat, using mixed-effects models. Results Diet resulted in reduction of percentage of fat intake (from 31 +/- 7% to 21 +/- 3% of calories), while controls presented no change in percentage of fat intake. Plasma cholesterol (from 151 +/- 29 mg/dl to 190 +/- 33 mg/dl) and low-density lipoprotein cholesterol (from 85 +/- 24 mg/dl to 106 +/- 31 mg/dl) increased in the control group and were unchanged in the diet group. Plasma triglycerides were reduced by diet (from 135 +/- 67 mg/dl to 101 +/- 42 mg/dl) and increased in the control group (from 134 +/- 70 mg/dl to 160 +/- 76 mg/dl). After 1-year follow-up, 21% of patients who received diet had lipid profile compatible with dyslipidemia compared with 68% (p < 0.001) of controls. Conclusions Among HIV-1-positive individuals naive of previous treatment, diet prevents dyslipidemia associated with HAART. (Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial; NCT00429845) (J Am Coll Cardiol 2012;59:979-88) (C) 2012 by the American College of Cardiology Foundation
引用
收藏
页码:979 / 988
页数:10
相关论文
共 37 条
  • [11] Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon, S
    Carr, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01) : 48 - 62
  • [12] LIPIDS, LIPOPROTEINS, TRIGLYCERIDE CLEARANCE, AND CYTOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    GRUNFELD, C
    PANG, MY
    DOERRLER, W
    SHIGENAGA, JK
    JENSEN, P
    FEINGOLD, KR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) : 1045 - 1052
  • [13] Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: A meta-analysis of randomized, controlled trials
    Halbert, JA
    Silagy, CA
    Finucane, P
    Withers, RT
    Hamdorf, PA
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1999, 53 (07) : 514 - 522
  • [14] Dramatic improvement in survival among adult Brazilian AIDS patients
    Marins, JRP
    Jamal, LF
    Chen, SY
    Barros, MB
    Hudes, ES
    Barbosa, AA
    Chequer, P
    Teixeira, PR
    Hearst, N
    [J]. AIDS, 2003, 17 (11) : 1675 - 1682
  • [15] A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia
    Miller, J
    Brown, D
    Amin, J
    Kent-Hughes, J
    Law, M
    Kaldor, J
    Cooper, DA
    Carr, A
    [J]. AIDS, 2002, 16 (16) : 2195 - 2200
  • [16] Ministerio da Saude Secretaria de Vigilancia em Saude Programa Nacional de DST e AIDS, 2008, REC ANT THER AD AD I
  • [17] Möbius U, 2005, JAIDS-J ACQ IMM DEF, V39, P174
  • [18] A review on linear mixed models for longitudinal data, possibly subject to dropout
    Molenberghs, Geert
    Verbeke, Geert
    [J]. STATISTICAL MODELLING, 2001, 1 (04) : 235 - 269
  • [19] Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy
    Moyle, GJ
    Lloyd, M
    Reynolds, B
    Baldwin, C
    Mandalia, S
    Gazzard, BG
    [J]. AIDS, 2001, 15 (12) : 1503 - 1508
  • [20] Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients
    Negredo, E
    Ribalta, J
    Ferré, R
    Salazar, J
    Rey-Joly, C
    Sirera, G
    Masana, L
    Clotet, B
    [J]. AIDS, 2004, 18 (05) : 819 - 821